PE Anti-PDGFR alpha antibody [EPR22059-270]
- RabMAb
- Recombinant
- What is this?
0
(1 Review)
|
(1 Publication)
Rabbit Recombinant Monoclonal PDGFR alpha antibody - conjugated to PE. Suitable for Flow Cyt, ICC/IF, IHC-P and reacts with Human, Mouse, Rat samples. Cited in 1 publication.
View Alternative Names
CD140a, PDGFR2, RHEPDGFRA, PDGFRA, Platelet-derived growth factor receptor alpha, PDGF-R-alpha, PDGFR-alpha, Alpha platelet-derived growth factor receptor, Alpha-type platelet-derived growth factor receptor, CD140 antigen-like family member A, CD140a antigen, Platelet-derived growth factor alpha receptor, Platelet-derived growth factor receptor 2, PDGFR-2
- Flow Cyt
Lab
Flow Cytometry - PE Anti-PDGFR alpha antibody [EPR22059-270] (AB270086)
Flow cytometry overlay histogram showing left SH-SY5Y (human neuroblastoma cell line from bone marrow) positive cells and right negative A431 (human epidermoid carcinoma cell line) cells stained with ab270086 (red line). The cells were incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab270086) (1x 106 in 100μL at 0.2μg/mL (1/2500)) for 30 min on ice.
Isotype control antibody (black line) was Rabbit IgG (monoclonal) Phycoerythrin (ab209478) used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.
Acquisition of >5000 events were collected using a 50 mW Yellow/Green laser (561nm) and 585/42 bandpass filter.
Related conjugates and formulations (4)
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-PDGFR alpha antibody [EPR22059-270]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-PDGFR alpha antibody [EPR22059-270]
-
Anti-PDGFR alpha antibody [EPR22059-270]
-
Anti-PDGFR alpha antibody [EPR22059-270] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PDGFR alpha mediates cell proliferation survival and differentiation especially in embryonic development and wound healing. The receptor often forms a complex by dimerizing with itself or with PDGFR beta to activate intracellular signaling cascades. This process is initiated upon ligand binding which triggers autophosphorylation on tyrosine residues. The receptor is also recognized in the detection of PDGFRA with assays such as PDGFRA ELISA.
Pathways
PDGFR alpha significantly affects the MAPK and PI3K/AKT signaling pathways which regulate cellular growth and survival signals. Through these pathways PDGFR alpha interacts with related proteins like SHP-2 and PI3K contributing to signal transduction involved in cellular responses. This role links PDGFR alpha to important cellular processes via its kinase activity and signal integration.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Animal bioscience 38:1342-1355 PubMed40211848
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com